C-terminal HSP90 Inhibitors Block the HSP90:HIF-1α Interaction and Inhibit the Cellular Hypoxic Response
Preprint
- 24 January 2019
- preprint
- Published by Cold Spring Harbor Laboratory in bioRxiv
- p. 521989
Abstract
Hypoxia Inducible Factor (HIF) is a transcription factor activated by low oxygen, which is common in solid tumours. HIF controls the expression of genes involved in angiogenesis, chemotherapy resistance and metastasis. The chaperone HSP90 (Heat Shock Protein 90) stabilizes the subunit HIF-1α and prevents degradation. Previously identified HSP90 inhibitors bind to the N-terminal pocket of HSP90 which blocks binding to HIF-1α, and produces HIF-1α degradation. N-terminal inhibitors have failed in the clinic as single therapy treatments due in part because they induce a heat shock response, which increases chemotherapy resistance. SM molecules are HSP90 inhibitors that bind to the C-terminus and do not activate the heat shock response. The effects of C-terminal HSP90 inhibitors on HIF-1α are unreported. Herein we show that SM compounds block binding between HSP90 and HIF-1α, leading to HIF-1α degradation through the proteasome using the PHD/pVHL pathway in hypoxic conditions. The SM compounds decrease HIF-1α target gene expression at the mRNA and protein level under hypoxia in colorectal cancer cells, leading to cell death, without inducing a heat shock response. Our results suggest that targeting the C-terminus of HSP90 blocks the hypoxic response and may be an effective anti-cancer strategy.Keywords
This publication has 26 references indexed in Scilit:
- Models of intermittent hypoxia and obstructive sleep apnea: molecular pathways and their contribution to cancerAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2018
- Screening and Biological Effects of Marine Pyrroloiminoquinone Alkaloids: Potential Inhibitors of the HIF-1α/p300 InteractionJournal of Natural Products, 2016
- Inhibition of the HIF1α-p300 interaction by quinone- and indandione-mediated ejection of structural Zn(II)European Journal of Medicinal Chemistry, 2015
- A Cyclic Peptide Inhibitor of HIF-1 Heterodimerization That Inhibits Hypoxia Signaling in Cancer CellsJournal of the American Chemical Society, 2013
- Angiogenesis Inhibitors: Current Strategies and Future ProspectsCA: A Cancer Journal for Clinicians, 2010
- Epidithiodiketopiperazines Block the Interaction between Hypoxia-inducible Factor-1α (HIF-1α) and p300 by a Zinc Ejection MechanismJournal of Biological Chemistry, 2009
- Echinomycin, a Small-Molecule Inhibitor of Hypoxia-Inducible Factor-1 DNA-Binding ActivityCancer Research, 2005
- Small molecule blockade of transcriptional coactivation of the hypoxia-inducible factor pathwayCancer Cell, 2004
- Aryl Hydrocarbon Nuclear Translocator (ARNT) Promotes Oxygen-independent Stabilization of Hypoxia-inducible Factor-1α by Modulating an Hsp90-dependent Regulatory PathwayJournal of Biological Chemistry, 2004
- Hsp90 Regulates a von Hippel Lindau-independent Hypoxia-inducible Factor-1α-degradative PathwayJournal of Biological Chemistry, 2002